Pharmaceuticals, Biotechnology and Life Sciences
The primary objective is to determine the effect of daily oral administration of elafibranor on serum alkaline phosphatase (ALP) in these patients, based on relative change versus placebo.
FDA granted accelerated approval to Lartruvo (olaratumab) injection, in combination with doxorubicin, for the treatment of adult patients…
Cardinal Health has announced on Thursday that the board of directors approved a regular quarterly dividend…
Gelesis, focused on developing first-in-class products to safely induce weight loss and improve glycaemic control, has presented new data for its second product candidate, Gelesis200
Horizon Pharma has announced that Ravicti (glycerol phenylbutyrate) Oral Liquid is now available in Canada through its affiliate….
Alkermes, a global biopharmaceutical company developing medicines for the treatment of central nervous system…
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
ValiRx’s new cancer drug VAL401 progresses into the clinic
Mereo reports positive outcome of its phase 1 study of acute exacerbations of COPD drug
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.